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Optimizing tissue-clearing 
conditions based on analysis of 
the critical factors affecting tissue-
clearing procedures
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Jaeho Cho  4, Keun-Tae Kim5, Hyuk-Jin Cha6 & Woong Sun  1
Tissue-clearing techniques have received great attention for volume imaging and for the potential 
to be applied in optical diagnosis. In principle, tissue clearing is achieved by reducing light scattering 
through a combination of lipid removal, size change, and matching of the refractive index (RI) between 
the imaging solution and the tissue. However, the contributions of these major factors in tissue 
clearing have not been systematically evaluated yet. In this study, we experimentally measured and 
mathematically calculated the contribution of these factors to the clearing of four organs (brain, liver, 
kidney, and lung). We found that these factors differentially influence the maximal clearing efficacy 
of tissues and the diffusivity of materials inside the tissue. We propose that these physical properties 
of organs can be utilized for the quality control (Q/C) process during tissue clearing, as well as for the 
monitoring of the pathological changes of tissues.
Understanding the architecture of an organ or the body as a whole, using cellular resolution, is one of the ulti-
mate goals in biology. The recent explosion of tissue-clearing techniques, which have been successfully applied 
to glimpse whole or parts of body structures, reflects this demand1–4. The enhancement of tissue transparency 
is achieved by the reduction of light scattering. Theoretically, light scattering occurs due to the inhomogeneity 
of materials with different refractory indices (RI)5 and spatial arrangement of scatters6,7. Therefore, tissue clear-
ing requires the reduction of light scattering either by diluting/removing materials that induce light scattering 
(such as membrane lipids), swelling or shrinkage of tissues to alter the structure of scattering sources such as 
extracellular matrix (ECM), or by reducing the RI difference, using adjusting media with RI value similar to the 
average RI of tissue components. All the currently available protocols are designed based on these principles8. 
Considering that organs/tissues have different macromolecule contents and unique histological signatures9,10, 
their optical properties and responses to different tissue-clearing methods should also be different. However, the 
clearing-related properties of organs have not yet been comprehensively explored, which makes choosing the best 
clearing methods for the desired organs difficult.
To this end, we developed assay systems to analyze the differential clearing properties of organs/tissues and to 
evaluate the quality of tissue clearing based on the changes in their macromolecule components and transparency. 
This battery of assays allows for the systematic monitoring of the clearing processes, which can then be used as 
quality control methods for the standardization of the clearing process. Furthermore, our protocols can be used to 
verify the pathological changes of tissues, which will be a foundation for the label-free diagnosis of tissues based 
on optical clearing methods.
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Results
Differential contribution of factors affecting tissue clearing. To evaluate the contributions of major 
factors, we employed our recently published active clarity technique (ACT) for tissue clearing4. We re-defined the 
ACT process into 5 steps as shown in Fig. 1a,b: 1) fixation and polymerization, 2) RI-matching before lipid-ex-
traction, 3) electrophoretic tissue clearing (ETC) in Sodium dodecyl sulfate (SDS) solution to remove lipid from 
the tissue, 4) washing with phosphate buffer saline (PBS) after ETC, and 5) RI-matching after ETC. Changes in 
1-mm-thick tissues from the brain, liver, kidney, and lung in each step are shown in Fig. 1b. The transparency 
and size of four tissues in each step were quantified (Fig. 1c,d). The thickness of the specimens exhibited strong 
negative correlation with their transparency under the same RI-matching condition (Suppl. Fig. 1), and we chose 
1-mm thickness for further analyses. Based on these measurements, we calculated the contributions to tissue 
transparency of: 1) lipid extraction, by comparing the transparency of tissues in PBS before ETC (①) with that 
of tissues washed by PBS after the ETC step (④); 2) RI-matching, by comparing the transparency of a tissue in 
PBS (④) with that in CUBIC-mount solution (CM)4 (⑤); and 3) size expansion, by comparing the transparency 
of a tissue in SDS after ETC (③) with that of a tissue in PBS (④). The difference in transparency obtained by 
the last comparison was primarily owing to the tissue expansion, because the RIs of SDS solution and PBS were 
similar (1.3339 vs. 1.3343). We additionally compared the tissue size and transparency in various concentrations 
of PBS (0.1–10×) and found that the correlation between size change and transparency was very similar in all 
Figure 1. ACT process and contributions of lipid-extraction, RI-matching, and size expansion to tissue 
transparency (a) Schematic diagram of refractive index (RI) matching and the active CLARITY technique 
(ACT) process. (b) Images of 1-mm-thick tissue slices during the tissue-clearing process. Comparison of two 
different steps provides contributions of each factor (bottom) (c) Transparency of each organ tissue during the 
tissue-clearing process. (d) Size changes of each organ at each tissue-clearing step. (e) Contributions of RI-
matching and lipid extraction to tissue clearing, if the effect of size change on transparency is compensated. (f) 
3D plot of contributions of lipid-extraction and RI-matching to tissue transparency. The color indicates the final 
transparency (red-green-blue). N = 3 for each organ.
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organs (Suppl. Fig. 2). However, the cleared tissue in CUBIC-mount solution returned to its original size, and 
we obtained the contributions of lipid extraction and RI-matching to tissue transparency for each organ by nor-
malizing the scores based on their tissue size at the given step (Fig. 1e). The relationships of the contributions of 
lipid extraction and RI matching to the final transparency of different organs are shown in Fig. 1f, illustrating the 
differences in the tissue-clearing properties.
In general, the contribution rate of lipid extraction is smaller in organs which exhibited larger swelling in size 
(brain, liver), comparing to organs exhibiting less change (kidney, lung). In fact, the change of transparency by 
RI-matching can be achieved before ETC (with lipid; ②-①) and after ETC (after removal of lipids, ⑤-④). The 
contribution of RI-matching to tissue transparency increased in “large-size-change” tissue (brain, liver) by ETC, 
but decreased in “small-size-change” tissue (kidney, lung) (Suppl. Fig. 3). Thus, we reasoned that lipid extraction 
made tissue more porous and expandable, and RI solution will easily infuse and replace the void volume of an 
ETC-processed tissue. On the other hand, the RI-matching effect should decrease after lipid extraction, because 
of the relatively high RI of lipids (RI 1.44–1.49;11). Thus, this trade-off in lipid extraction effects seems to differen-
tially influence the tissue-clearing process.
Evaluation of lipid extraction. As a step toward understanding the precise mechanism by which the 
lipid extraction step differentially contributes to tissue clearing, we first investigated the changes in transparency 
during ETC. DiI [(2Z)-2-[(E)-3-(3,3-dimethyl-1-octadecylindol-1-ium-2-yl)prop-2-enylidene]-3,3-dimethyl- 
1-octadecylindole; perchlorate] is commonly used for visualizing lipids in the cell membrane. We established 
an assay measuring the level of DiI-labeled lipids in each specimen and found that it was well correlated with 
the amount of cells estimated by DNA contents in the tissues (Suppl. Fig. 4), suggesting that the DiI level faith-
fully represents the amount of lipids associated with cell membranes. Fig. 2a,c show that the extraction profiles 
of DiI-labeled lipids during ETC are different in each organ. Interestingly, two different extraction rates were 
observed in all organs. Fast extraction occurred for 1–3 hr of ETC (thick red line in Fig. 2c), and thereafter, 
slow extraction was seen (thick blue line in Fig. 2c), suggesting that a subset of DiI-labeled lipids are efficiently 
extracted by ETC with SDS buffer but some other species of lipids are extracted much more slowly. Accordingly, 
when CM-DiI was pre-loaded to the vasculature of a mouse brain by cardiac perfusion before ETC, substantial 
DiI signals were remained after 2 hr of ETC when slow extraction was not yet completed (Fig. 2b). Furthermore, 
the extraction profile of other lipid species labeled with Oil-Red-O (ORO) was markedly different from that of 
Figure 2. Evaluation of lipid extraction (a) Images of DiI-stained tissue at different ETC time points. (b) 
Pre-labeled CM-DiI signals remaining in the brain vasculature before (left) and after 2 hr ETC (right). Lipid 
extraction rate (c) and transparency (d) at different ETC time points. “X” marked points in (d) indicate 
an optimal time point for each organ for maximal clearing. N = 3, 3, 6, 6 for brain, lung, liver and kidney, 
respectively. (e) Correlation graph of extracted lipid and contribution of lipid extraction to the improvement of 
the transparency of each organ.
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DiI-labeled lipids (Suppl. Fig. 5). Therefore, the transparency of four organs at different ETC time points was not 
well correlated with the extraction rate of either DiI-labeled or ORO-labeled lipids (Fig. 2d; Suppl. Fig. 5), and the 
total amount of extracted DiI-labeled lipids exhibited no correlation with the contribution of lipid extraction to 
the transparency change in each organ (Fig. 2e). Collectively, ETC-based lipid extraction can be achieved by fast 
extraction in 1–6 hr for most organs, and an additional 12 hr of ETC might be required for some organs in which 
lipid extraction greatly contributes to the tissue clearing.
Evaluation of tissue ECM components and RI matching. The major source of light scattering in 
lipid-removed tissues may be extracellular matrix proteins (ECM), which are the richest tissue components in 
most organs. Thus, we explored the relationship between ECM components and RI matching in different tissues. 
Immuno-labeling images of collagen IV provide an overview of the differences in the density and structures of the 
ECM in different organs (Fig. 3a). The changes of tissue transparency in solutions with different RI scores were 
measured and their correlation slope was obtained (Suppl. Fig. 6). The transparency variation based on solution 
RI changes was highly correlated with the amount of collagen IV in specimens (Fig. 3b), indicating that ECM 
components are the main determinants of RI matching-based tissue clearing. Interestingly, the contribution of 
RI-matching calculated in Fig. 1 fitted with the maximum transparency of fully cleared tissues (Fig. 3c), but the 
orders of tissues in Fig. 3b (brain < kidney < liver < lung) and Fig. 3c (kidney < lung < brain < liver) are differ-
ent. Thus, we speculated that not only the total amount but also the arrangements of the ECM contribute to RI 
matching-based tissue clearing. Because ECM architecture cannot be experimentally modified, a finite-difference 
time-domain (FDTD) simulation with randomly generated images (Suppl. Fig. 7) for various ECM densities was 
designed to address this issue. As a result, both the density and structure of the ECM were considered to have 
major roles in light transmittance (transparency). Light transmittance showed a linear correlation to ECM density 
with negative slop, whereas quite a wide range of light transmittance was shown in similar-density ECM (Fig. 3d).
Establishment of a molecular diffusion-based evaluation method for the ACT-processed specimen. 
As mentioned above, specimens with the same transparency would have different conditions (e.g., different level 
of lipid removal). Cleared specimens are often subject to further processing for optical examinations with fluores-
cent labeling of specific macromolecules1,3,4,12–14. Because these labeling methods include the diffusion of probes/
dyes into the tissues, it is especially important to verify the porosity of the cleared tissue samples. However, the 
tissue transparency is determined by multiple factors, and it does not indicate the quality of the tissue. Thus, we 
propose a simple method to evaluate the status of tissues by measuring their transparency and the diffusion rate 
of RI-matching solution which are composed of micro-molecules, such as glucose and ethylene glycol whose 
Figure 3. Evaluation of collagen IV and RI matching (a) Immunostained images of each organ with collagen IV, 
which is one of the main components for light scattering in tissues. (b) Correlation between the actual collagen 
amount and variation of transparency on different levels of RI-matching. Also see Suppl. Fig. 6. Average values 
of triplicated samples were used. (c) Maximum transparency of fully cleared tissue determined by contribution 
of RI-matching (ECM). (d) Finite-difference time-domain (FDTD) simulation with randomly generated images 
of various ECM density showing that light transmittance is dependent on ECM density (from negative slop of 
the linear fitting line) and ECM structures (from red points having similar ECM density).
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diffusion properties were well documented by the recent study15. The experimental process is summarized in 
Fig. 4a. First, a specimen in PBS after ETC is placed in an imaging setup, such as a microscope, or a simple system 
in a dark room composed of a backlight and camera, which collects the transmitted light. PBS solution is then 
replaced by RI-matching solution, and time-lapse images are acquired until tissue clearing reaches the plateau. 
The time-lapse images are segmented into many square tiles with a fixed unit size (i.e., 50 μm x 50 μm). The 
changes in local transparency of each tile are then automatically calculated to deduce the maximum transparency 
and time constant (τ) by fitting the time series to the one-phase association function (Fig. 4b). The estimated τ 
values in all tissues progressively decreased as ETC duration increased, suggesting that the τ values are propor-
tional to the tissue porosity, which is increased by the removal of lipids (Fig. 4c). The comparisons of transparency 
and τ maps (middle and right in Fig. 4d, respectively) showed gross similarity, but they were not completely 
matching owing to the local concentration difference of ECM/proteins, which were not extracted by ETC. Thus, 
the τ-transparency scatter plot of each tile clearing demonstrates the changes/status of the specimens (Fig. 4e). In 
this plot, the dots are spotted from top to bottom depending on the amount of light scattering by the tissue area 
(tile), whereas the dots are positioned right to left as the degree of porosity increases. Indeed, a shift of the spots 
Figure 4. Molecular diffusion-based evaluation method for tissue clearing (a) Conceptual image showing the 
evaluation process of tissue clearing with two variables: transparency and time constant (τ) for the diffusion of 
RI-matching solution. (b) Time-transparency data fitted to one-phase association function to get time constant 
and final transparency. (c) τ profile of each organ at different ETC time points. (d) Sample images of the same 
mouse kidney slice: bright-field image (left), transparency map (middle), τ map (right). (e) τ-transparency 
scatter plot, which could indicate the optical properties of a cleared tissue. Each data points were obtained from 
3 independent samples in each organ at each ETC time point. (f) τ and transparency relations for each points 
of a kidney sample before (red dots) and after 12 hr ETC (blue dots) and their position change (colored arrows). 
The colors of arrow were from τ values before ETC. (g) Images of mouse kidney at ETC 0 and 12 hr. (h) Scatter 
plot of τ-transparency from samples in (g).
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6SCientifiC REPORTS |  (2018) 8:12815  | DOI:10.1038/s41598-018-31153-7
from the lower-right to upper-left side was observed in tissues with the progression of ETC (Fig. 4f). To confirm 
the relationship between τ (porosity) and lipid extraction, the binned map of DiI fluorescent image was compared 
with the τ map of the sample tissue (Fig. 4h), showing same shift of spots from lower-right to upper-left (Fig. 4g). 
As a result, correlation coefficients between the maps of DiI and τ were 0.71 (0 hr) and 0.59 (12 hr), indicating that 
τ mainly reflects the distribution of lipid in a tissue. Therefore, the profile of τ-transparency plots can be used for 
evaluating the degree of lipid extraction from a tissue.
Application of tissue-clearing procedure for the diagnosis of tissue injury. Finally, we tested 
whether changes in the optical status of tissues during the clearing procedure could be used to evaluate tissue 
quality under pathological conditions. Traumatic brain injury (TBI) is known to cause astrogliosis and tissue 
remodeling, including the deposit of ECM molecules at the penumbra area of the injury spots16–18. Accordingly, 
tissue clearing enhanced the contrast between the normal vs. injured area (Fig. 5a). Similarly, enhanced opti-
cal contrast with fibrosis was also found in the focal lung fibrosis model (Suppl. Fig. 8). This enhanced optical 
contrast coincides with the deposit of collagens in the injured area (insets, Fig. 5a), whereas the time-course for 
cell accumulation and gliosis appears to be earlier than that for the development of optical contrasts19. In the 
sectioned tissues, the τ-transparency map demonstrated that the injured area moved toward the lower-right posi-
tion (Fig. 5a), and the average transparency and τ values were accordingly reduced and increased, respectively 
(Fig. 5b). These results indicate that ECM deposition occurred in the injured area, which can be captured by the 
currently developed procedure (Fig. 5c).
Discussion
In this study, we comprehensively analyzed the factors affecting tissue clearing, and we propose novel methods to 
evaluate the status of tissue clearing, which also can be used as markers for tissue injury. Optical tissue clearing 
is achieved by the combination of 3 major factors: lipid removal, size expansion, and RI adjustment. Because the 
composition and structure of tissues are different, the contributions of these factors on tissue clearing are also 
tissue-specific.
Among the sample organs we tested, the contribution of lipid extraction was high in the kidney and lung, 
whereas low contribution was found in the liver and brain. Thus, satisfactory optical clearing can be achieved 
by simple RI adjustment in some tissues for which the lipid contribution is low. Accordingly, as a study reported 
that simple immersing a tissue into saline was sufficient to achieve local RI matching for lung tissue20, several 
Figure 5. Diagnostic application of tissue clearing (a) Images of mouse brain 3, 7, and 14 days after cryogenic 
TBI. (From left to right) bright-field images of whole brain before (Fix) and after tissue clearing (ACT); section 
images of injured brain regions stained with collagen IV (red; ECM accumulation), GFAP (green; reactive 
astrogliosis); 1-mm-thick brain slice including both injured and normal regions; transparency and τ maps; and 
scatter plot of τ-transparency showing the optical condition of the tissues. Insets show the superimposed images 
of immunolabelings and optical contrast (pseudocolored with inversed blue). The sizes of scale bars in (a) are 
5 mm for Fix and ACT, 400 μm for immunostaining, and 1 mm for Section. (b) Transparency and τ profiles 
of normal and injured areas at 3, 7, and 14 days after TBI. Mean ± SD for tiles of normal area at TBI days 3, 7, 
14 (N = 37, 71, 68 respectively) and injury area at TBI days 3, 7, 14 (N = 89, 54, 46 respectively). **P < 0.01, 
***P < 0.001 compared to control determined by one-way ANOVA with post-hoc Tukey (c) Proposed 
diagnostic process for deformed tissue, using tissue clearing and τ measurement.
www.nature.com/scientificreports/
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tissue-clearing techniques such as SeeDB21 and Scale22, which do not include a lipid extraction step, have been 
successfully used for brain tissue clearing. In contrast, organs in which lipid extraction has a higher contribution 
should be processed using techniques that include lipid extractions, such as CLARITY1, iDISCO2, and CUBIC3. 
We also found that the kinetics of lipid extraction is not linear, and at least two different extraction kinetics of 
DiI-labeled lipid components were recognized, although the exact identification of these molecules needs to be 
further explored. We reasoned that there are roughly two different groups of DiI-labeled lipids: SDS-extractable 
(fast component) or SDS-insoluble (slow component). Removal of the fast component could be achieved within 
1–3 hr in all the organs we tested, whereas the remaining components were slowly removed in >24 hr. Thus, it 
is difficult to remove these slow components of lipids completely using SDS-based ETC methods, and extended 
ETC (>24 hr) might cause tissue damage. Therefore, these would serve as a limiting factor for thicker tissue clear-
ing using the ACT protocol. It should also be noted that some lipid components cannot be efficiently recognized 
by DiI. For instance, lipid droplets in the cells were not labeled with DiI, and lipids in adipose tissues were not 
efficiently removed by SDS (Suppl. Fig. 5). Therefore, the complete removal of lipid species is not achievable when 
using an SDS-based protocol, and organic solvent-based methods such as DISCO series2,23,24 or CUBIC3 should 
be considered. On the other hand, the remaining lipophilic CM-DiI in the ACT protocol can be used for the 
post-clearing detection of DiI signals such as vasculatures as shown in Fig. 2b. However, because extended ETC 
will progressively remove DiI signal from weakly labeled capillaries, caution is necessary for using this technique 
for high-fidelity, quantifiable analysis.
Size changes during tissue clearing vary depending on the technique used. Because tissue expansion results 
in the dilution of materials causing light scattering, hyper-hydration of tissues in urea solution has been utilized 
to enhance the transparency of tissues. ETC also causes mild tissue expansion, which transiently affected tis-
sue transparency. With this advantage, expansion microscopy was introduced25. However, a size change is not 
desirable in many applications because of the distortion caused by anisotropic expansion/shrinkage, and there 
are modified versions of tissue clearing with adjustments made to the clearing solution to prevent size changes. 
Interestingly, we found that different organs exhibit unique swelling property, which do not appear to be asso-
ciated with tissue softness or ECM contents. For example, lung is relatively soft-tissue organ, but size expansion 
was relatively small. We speculate that sponge-like structure of lung somehow prevents external expansion from 
hyper-hydration, and the tissue organization appear to be an important factor for tissue swelling. In the ACT 
procedure, the cubic-mount solution is also adjusted to maintain the original tissue size, and the contribution 
of tissue expansion is negligible. In view of the size, it is interesting that the use of organic solvents in iDISCO 
induces marked tissue shrinkage with enhanced tissue transparency2,6,26. It appears that organic solvents causes 
strong dehydration, and shrinkage owing to osmotic pressure by dehydration15 induces quasi-crystallization of 
the remaining tissue components. Thus, the homogeneity of the component should increase, and the light scat-
tering should be reduced. Based on this notion, recently we demonstrated that complete drying of ACT-processed 
samples can transform them into film-like, highly transparent thin sheet, which can be used to reduce imaging 
burden26.
After lipid removal, the RI of ACT-processed tissues are primarily determined by the protein component in 
tissues. Since ECM proteins are the most abundant species of proteins in organs, it appears that the amount of 
ECM proteins is highly correlated with the contribution of RI matching. However, as discussed above, the homo-
geneity of the tissue (i.e., arrangements of the ECM in organs) should be a factor influencing tissue transparency, 
and the mathematical simulation supported this notion. Because ECM arrangements are unique signatures of 
each organ, these results indicate that organs have unique features of tissue clearing based on their protein com-
position, ECM contents, and ECM arrangements. Both lipid extraction and ECM arrangements are important 
factors affecting the diffusion of materials27. In fact, the homogeneous diffusion of antibody deep into a thick 
tissue or whole organ is crucial for imaging the specific target labeled by a fluorescence protein. For this reason, 
measuring tissue porosity is important, but an appropriate method is currently lacking. In this respect, the anal-
ysis of τ-transparency relationships, including spatial information, provides a simple and reliable parameter to 
evaluate tissue porosity and the degree of tissue clearing. Additionally, analyzing the slop of scattered points from 
lower-left to upper-right in τ-transparency plot of an uncleared tissue can give hints about the ETC time to be 
needed. It is important to note that the diffusion kinetics of the optical clearing reagents are inversely associated 
with the kinetics of water flux from the specimen15,28. Accordingly, de-lipidation causes tissue hydration and 
swelling, while optical clearing reagent reverses it via water efflux. For more accurate prediction, regular shaping 
of specimens or de-coloration step29 for pigmented organ tissues such as liver and kidney might be helpful.
The measuring light scattering and diffusion of optical clearing solution for ex vivo diagnosis had been 
proposed28,30. Likewise, changes in tissue architecture due to the pathological deposition of ECM can be effi-
ciently monitored by simple tissue clearing and the measurement of transparency. The diagnostic application 
of tissue-clearing methods has been proposed in many studies, because 3D imaging provides precise volume 
information of intact tissue13,14,31, compared with the conventional sectioning methods. Most proposed methods 
that utilize tissue clearing for diagnosis are based on fluorescence imaging with enhancement of transparency32–34. 
On the other hand, we propose that optical properties after tissue clearing per se can be used for the label-free 
assessment of tissue conditions and an optical diagnosis. In addition to our current demonstrations in TBI and 
pulmonary fibrosis models, our method can be applied to other diseases exhibiting ECM modifications which 
include cancer28 and dermatopathy30.
In summary, multiple factors affecting tissue transparency during the tissue-clearing process of the brain, liver, 
kidney, and lung were comprehensively investigated, and how the specific characteristics of different organ tissues 
contribute to the reduction of light scattering or the improvement of tissue porosity was clarified. We propose that 
this information can be used to develop a novel quality control (Q/C) process for tissue clearing and diagnosing 
tissue deformation.
www.nature.com/scientificreports/
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Methods
Tissue preparation and tissue clearing. All animal husbandry, animal care, and euthanasia protocols 
were in accordance with guidelines from the Korea University and have been approved by members of the Korea 
University Institutional Animal Care and Use Committee (KUIACUC-20150520-1). Mouse organs were cleared 
with ACT as described in a previous study4. Briefly, 7-week-old C57BL/6 mice (DAEHAN Biolink, Inc, Korea.) 
were transcardially perfused with PBS and paraformaldehyde (PFA), and fixed organ samples were dissected 
and incubated in hydrogel solution overnight at 4 °C. Hydrogel-infused organs were polymerized for 2–3 hr after 
degassing. Polymerized samples were cut into 1-mm-thick tissue slices and electrophoresed for fast removal 
of lipid, using an ETC apparatus (X-CLARITY, Logos systems, Republic of Korea) with following conditions: 
1.5 mA, 37 °C. Electrophoretic times for maximal lipid extraction from organ tissues without significant tissue 
damage were 3, 18, 12, and 24 hr for brain, liver, kidney, and lung tissues, respectively. Brain tissue was cut into 
coronal slices, whereas other organs were sliced transversally. For RI-matching to achieve clearer images, CUBIC-
mount solution [250 g sucrose (50%, w/v), 125 g urea (25%, w/v), and 125 g N,N,N′,N′ -tetrakis (2-hydroxypropyl)
ethylenediamine (25%, w/v) dissolved in 150 ml of dH2O and brought up to 500 ml] was used4.
Measurement of transparency. Fixed adult mouse organs were cut into 1-mm-thick slices. The slices 
were imaged using a conventional camera before and after clearing. We measured the size and transparency of 
the cleared 1-mm-thick organ slices, which were outlined and calculated using ImageJ (NIH, USA). The gray 
value of the cleared sample image was used to measure tissue transparency, and transparency was normalized to 
the background part of the image. For τ measurements, transparency was acquired by fitting with the one-phase 
association function [see Methods section Time constant (τ) of diffusion measurement].
Calculation of contributions of factors to transparency. The contributions of factors to tissue trans-
parency were calculated the difference in transparency between the two different steps. When Tn is transparency 
at the step n (①-⑤), the contribution of the factor α (Cα) is followed,
= −C T T (1)Lipid 4 1
= −−C T T (2)RI matching 5 4
= −C T T (3)Size 3 4
Measurement of size change. To evaluate the effect of size change on transparency of cleared tissues 
independently without RI-matching, it is crucial that the refractive index of the solutions used for changing size 
of tissue have to be preserved. For that, we used different concentration of PBS (0.1×, 0.5×, 1×, 5× and 10×) 
and 4% SDS, whose refractive indices were 1.3328, 1.3331, 1.3343, 1.3397, 1.3468 and 1.3339 respectively. All 
refractive indices in this study were measured at 589 nm by ATAGO PAL-RI (ATAGO CO., LTD., Tokyo, Japan).
Measurement of lipid in tissue using DiI staining. DiI (468495, Sigma-Aldrich, USA) is known to bind 
phospholipid; hence, we used it to measure the amount of phospholipid in a tissue. The tissue was immersed 
in 100% dimethyl sulfoxide (DMSO) for enough time to improve the homogenous loading DiI deep into the 
tissue, after which it was again immersed in 0.2 mM DiI overnight. Finally, the tissue was washed in 1% SDS 
overnight, followed by extraction of lipids by soaking in 100% isopropanol for 4 hr. The extracted fluorescence 
value was measured using a Micro plate reader (SpectraMax Plus384, Molecular Devices, Sunnyvale, CA, USA) 
at 550 nm. For confocal imaging, a lower concentration of DiI (0.2 μM) was used to adjust the fluorescence inten-
sity. For labeling of vasculature with lipidophic dye, CM-DiI (Thermo Fisher Scientific, USA) was used, which is 
aldehyde-fixably modified version of DiI35. Adult C57BL/6 mice were anesthetized with urethane and transcar-
dially perfused with 50 ml of 0.9% saline, 20 ml of 0.01% CM-DiI solution followed by 20 ml of 4% paraformalde-
hyde for fixation. Fixed brains were cut into 1-mm thick coronal slices and were cleared by ACT for 2 hr. Cleared 
tissue samples were incubated in CUBIC-mouse solution for 1 h. Image was acquired using a TCS SP8 confocal 
laser-scanning microscope (Leica, Germany) with a 10X lens (NA cq0.3, working distance .32.2 mm) and 568-nm 
excitation wavelength.
Measurement of lipid in tissue using Oil-Red-O staining. Oil-Red-O (ORO, O0625, Sigma-Aldrich, 
USA) is known to bind lipid droplets, so we used it to measure amount of lipid droplets in a tissue. The protocol 
of ORO staining and extraction was customized for our samples from the previous study36. Cleared tissues were 
immersed in ORO (2 mM in 100% isopropanol, 10 μL/mg) and incubated at room temperature for 2 hours. ORO 
stained tissues were washed tissue in 1% SDS overnight and lipid was extracted by soaking into 100% isopro-
panol for 4 hrs, and extracted fluorescence value was measured with Micro plate reader (SpectraMax Plus384, 
Molecular Devides, Sunnyvale, CA, USA) at 500 nm.
Immunohistochemistry. Cleared tissue organs were trimmed by 1-mm circular punch and incubated with 
primary antibody diluted in blocking solution (6% BSA and 0.2% Triton-X100 in 0.1X PBS) for 2 days at 37 °C 
shaker. Antibodies against Collagen IV (1:500, Millipore) and GFAP (1:1000, DAKO) was used. The samples were 
washed 3 times with 0.1x PBS, and incubated with secondary antibodies (1:500) for 2 days at 37 °C shaker by 
matching primary antibody host for fluorescence imaging.
www.nature.com/scientificreports/
9SCientifiC REPORTS |  (2018) 8:12815  | DOI:10.1038/s41598-018-31153-7
Collagen quantification. The collagen contents of samples were quantified using a Sircol collagen assay kit 
(Biocolor, Carrickfergus, UK) according to the manufacturer’s instructions. This step was done following collagen 
extraction by incubation for overnight in a pepsin-containing solution at 65 °C. The absorbance of each sample 
was determined at 550 nm using a microplate reader (Molecular Devices, CA, USA) and the collagen quantity 
was calculated by usage of a standard curve generated with water-soluble denatured collagen from bovine skin.
Finite difference time domain (FDTD) simulation. To investigate the effect of density and structure of 
ECM on tissue transparency, finite difference time domain (FDTD) simulation was performed. To describe large 
and fine virtual ECM structures, random images (45 μm ∗ 90 μm at 30 nm resolution) were created by random 
walk, following the various scale variable (γ) of levy distribution function (characteristic function:
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by a Matlab code (Suppl. Fig. 7). And for infinite area and finite thickness of virtual ECM structure, a periodic 
boundary condition was applied along the x-axis and, a perfectly matched layer was applied along y-axis. The 
refractive indices of background (water) and random dots (ECM) were set to 1.33 and 1.47 respectively. For 
one optical period, an x-polarized plane wave of 590 nm wavelength was normally incident to a virtual ECM 
structure, and the light transmittance was calculated by the ratio of transmitted energy to incident energy. For 
the steady state, the plane waves propagated for 5,000 optical periods. In-house FDTD code was used37 for all 
simulations of light transmittance.
Time constant (τ) of diffusion measurement. First, the glass bottom of a 35-mm-diameter black con-
focal dish (102350, SPL, Republic of Korea) was covered with a thin polydimethylsiloxane (PDMS) sheet, onto 
which a tissue stored in PBS was pinned using a short thin metal wire to prevent it from floating or moving when 
the solution was exchanged. PDMS is suitable for sample fixing for imaging because of its optical clarity and ease 
of treatment. The dish was mounted onto the stage of a microscope (EVOS FL, Thermo Fisher Scientific) and 
filled with PBS, and a reference image was acquired. The RI-matching solution was added into the dish right after 
the PBS in the dish was removed, and time-lapse images were acquired for 1–2 hr. The image was divided into 
small tiles measuring 50 μm x 50 μm. The changes in intensity with time for each tile was fitted to a one-phase 
association function ( y p y exp xf(x) ( ) [1 ( / )]0 0 τ= + − ⋅ − − )
6 to get the maximum values of transparency (P; 
plateau) and time constant (τ) of diffusion.
Traumatic brain injury (TBI). To induce cryogenic TBI, a metal probe with a diameter of 5 mm was cooled 
in liquid nitrogen. The head skin of anesthetized mice was cut, and the pre-chilled metal probe was placed in 
contact with the cranium of the mice for 30 seconds, as described previously38. The cut skin was sutured, and the 
animals were placed on a 37 °C hot plate until they were awake to be allowed to move freely in their home cage. 
Animals were sacrificed at 3, 7, and 14 days after TBI, and the whole brains were dissected and cleared by 6 hr 
ETC and were cut into the TBI region including the penumbra and undamaged periphery.
Pulmonary fibrosis induced by ionizing radiation. As described previously39, 3-mm collimator was 
used for introducing the 90 Gy radiation damage to the left lung of C57BL/6 male mice (8 weeks). Radiation was 
delivered with an X-RAD 320 (Precision, North Branford, CT, USA), equipped with a collimator system with 
5-cm-thick copper for focal radiation beams. Prior to irradiation, the mice were anesthetized with an intraperito-
neally administered mixture of 30 mg/kg of zoletil and 10 mg/kg of rompun. The animals were scarified 4 weeks 
after irradiation. For lung harvesting, the mice were anesthetized with an intraperitoneally administered mixture 
of 30 mg/kg of Zoletil (tiletamine 25 mg/kg with zolazepam 25 mg/kg) and 10 mg/kg of Rompun (xylazine 10 mg/
kg). Then 4% paraformaldehyde (PFA) solution was injected through trachea to fix the lung.
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